期刊文献+

抑癌基因PTEN在腮腺多形性腺瘤中的突变与缺失 被引量:2

Mutation and deletion of anti - oncogene PTEN in parotid pleomorphic adenoma
下载PDF
导出
摘要 目的探讨抑癌基因PTEN在腮腺多形性腺瘤的发生、发展过程中的作用。方法应用聚合酶链反应(PCR)及克隆、基因测序的方法来分析腮腺多形性腺瘤及正常腺体组织中PTEN基因第5、第6及第8外显子有无突变及缺失。结果通过对PTEN基因三个外显子的克隆测序,发现有2例外显子8发生突变,其中一例引起编码的氨基酸发生变化。结论初步判断,在DNA水平抑癌基因PTEN在腮腺多形性腺瘤中存在突变,在其发生发展过程中可能起到一定的作用。 Objective To investigate the role of anti-oncogene PTEN in the tumorigenesis and development of parotid pleomorphic adenoma. Methods The mutations of exon 5, exon 6, and exon 8 of PTEN gene were detected by PCR, gene clone, and DNA sequencing analysis in parotid pleomorphic adenoma and normal gland tissue. Results Two cases showed mutations at exon 8 of PTEN gene after DNA sequencing analysis. One resulted in coding amino acid change. Conclusion Anti-oncogene PTEN at the DNA level plays different roles in the tumorigenesis and development of parotid pleomorphic adenoma.
出处 《现代口腔医学杂志》 CAS CSCD 北大核心 2005年第1期57-59,共3页 Journal of Modern Stomatology
  • 相关文献

参考文献7

  • 1Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997,275 (5308): 1943 - 7.
  • 2Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet, 1997, 15(4) :356 - 362.
  • 3Li DM, Sun H. TEPt, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res, 1997,57 ( 11 ): 2124 -9.
  • 4Risinger J I, Hayes AK,Berchuck A, et al. PTEN/MMACt mutations in endometrial cancers. Cancer Res, 1997,57(21) :4736 - 4738.
  • 5Okami K, Wu L, Riggins G, et al. Analysis of PTEN/MMACtalterations in aerodigestive tract tumors. Cancer Res, 1998,58(3) :509 - 511.
  • 6Wang SI,Parson R, Ittmann M. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clin Cancer Res, 1998,4:811 - 815.
  • 7Wang SI, Puc J, Li J, et al. Somatic mutations of PTEN in glioblstoma multiform. Cancer Res, 1997,57: 4183 - 4186.

同被引文献28

  • 1陈润良,王昌美,温玉明.腮腺多形性腺瘤生物学行为相关因素的研究[J].中华口腔医学杂志,2004,39(4):277-279. 被引量:16
  • 2李超,陈建超,王朝晖,孙维刚,王影.头颈部鳞癌安全手术切缘的评价[J].中华口腔医学杂志,2006,41(8):478-480. 被引量:13
  • 3Silvoniemi A,Pulkkinen J,Grenman R.Parotidectomy in the treatment of pleomorphic adenoma-analysis of long-term results[J].Acta Otolaryngol,2010,130(11):1300-1305.
  • 4Zernial O,Springer IN,Warnke P,et al.Long-term recurrence rate of pleomorphic adenoma and postoperative facial nerve paresis (in parotid surgery)[J].J Craniomaxillofac Surg,2007,35(3):189-192.
  • 5Ungari C,Paparo F,Colangeli W,et al.Parotid glands tumours:overview of a 10-year experience with 282 patients,focusing on 231 benign epithelial neoplasms[J].Eur Rev Med Pharmacol Sci,2008,12(5):321-325.
  • 6Tarakji B,Nassani MZ.Survey of opinions on the management of pleomorphic adenoma among United Kingdom oral and maxillofacial surgeons[J].Kulak Burun Bogaz Ihtis Derg,2010,20(3):129-136.
  • 7Witt RL,Rejto L.Pleomorphic adenoma:extracapsular dissection versus partial superficial parotidectomy with facial nerve dissection[J].Del Med J,2009,81(3):119-125.
  • 8Wittekindt C,Streubel K,Arnold G,et al.Recurrent pleomorphic adenoma of the parotid gland:analysis of 108 consecutive patients[J].Head Neck,2007,29(9):822-828.
  • 9Koch M,Zenk J,Iro H.Long-term results of morbidity after parotid gland surgery in benign disease[J].Laryngoscope,2010,120(4):724-730.
  • 10Zbaren P,Stauffer E.Pleomorphic adenoma of the parotid gland:histopathologic analysis of the capsular characteristics of 218 tumors[J].Head Neck,2007,29(8):751-757.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部